Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Kaufman-Janette J, Avelar RL, Biesman BS, Draelos ZD, Gross JE, Jones DH, Lupo MP, Maas CS, Schlessinger J, Shamban AT, Sundaram H, Weinkle SH, Young VL. Kaufman-Janette J, et al. Among authors: jones dh. Aesthet Surg J. 2021 Nov 12;41(12):1494. doi: 10.1093/asj/sjab229. Aesthet Surg J. 2021. PMID: 34309676 Free PMC article. No abstract available.
The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Kaufman-Janette J, Avelar RL, Biesman BS, Draelos ZD, Gross JE, Jones DH, Lupo MP, Maas CS, Schlessinger J, Shamban AT, Sundaram H, Weinkle SH, Young VL. Kaufman-Janette J, et al. Among authors: jones dh. Aesthet Surg J. 2021 Nov 12;41(12):1409-1422. doi: 10.1093/asj/sjaa383. Aesthet Surg J. 2021. PMID: 33944905 Free PMC article. Clinical Trial.
DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).
Carruthers JD, Fagien S, Joseph JH, Humphrey SD, Biesman BS, Gallagher CJ, Liu Y, Rubio RG; SAKURA 1 and SAKURA 2 Investigator Group; SAKURA 1 and SAKURA 2 Investigator Group includes the following. Carruthers JD, et al. Plast Reconstr Surg. 2020 Jan;145(1):45-58. doi: 10.1097/PRS.0000000000006327. Plast Reconstr Surg. 2020. PMID: 31609882 Free PMC article. Clinical Trial.
Efficacy and safety of onabotulinumtoxinA for treating crow's feet lines alone or in combination with glabellar lines: a multicenter, randomized, controlled trial.
Moers-Carpi M, Carruthers J, Fagien S, Lupo M, Delmar H, Jones D, Somogyi C, Lee E, Lei X, MacKinnon S, Davis PG, Yalamanchili R, Campo A, Beddingfield FC 3rd. Moers-Carpi M, et al. Dermatol Surg. 2015 Jan;41(1):102-12. doi: 10.1097/DSS.0000000000000220. Dermatol Surg. 2015. PMID: 25485803 Clinical Trial.
Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis.
Carruthers J, Beer K, Carruthers A, Coleman WP 3rd, Draelos ZD, Jones D, Goldman MP, Pucci ML, VanDenburgh A, Weng E, Whitcup SM. Carruthers J, et al. Dermatol Surg. 2016 May;42(5):608-17. doi: 10.1097/DSS.0000000000000755. Dermatol Surg. 2016. PMID: 27124878 Free PMC article. Clinical Trial.
ASDS Cosmetic Dermatologic Surgery Fellowship Milestones.
Waldman A, Arndt KA, Avram MM, Brown MR, Dover JS, Fabi SG, Friedmann DP, Geronemus RG, Goldberg DJ, Goldman MP, Green JB, Ibrahimi OA, Jones DH, Kilmer SL, McDaniel DH, Obagi S, Ortiz AE, Rohrer TE, Taylor MB, Torres A, Weinkle SH, Weiss MA, Weiss ET, Weiss RA, Poon E, Alam M. Waldman A, et al. Among authors: jones dh. Dermatol Surg. 2016 Oct;42(10):1164-73. doi: 10.1097/DSS.0000000000000860. Dermatol Surg. 2016. PMID: 27661429
417 results